Letter: Dose and Donor Matter—Determining the Optimal Strategy for Faecal Microbiota Transplantation in Clostridioides difficile Infection
Alimentary Pharmacology & Therapeutics · 2026-08 · 64 (3) · 412-413
DOI: 10.1111/apt.70625 ↗Kurz gefasst
Leserbrief in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 17.03.2026. Verfasst von D Bogatic und 2 weiteren Autor:innen. Beteiligte Einrichtung: Inflammatory Bowel Disease Service, The Queen Elizabeth Hospital, Adelaide, South Australia, Australia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Inflammatory Bowel Disease Service, The Queen Elizabeth Hospital, Adelaide, South Australia, Australia.
- Inflammatory Bowel Disease Research Group, The Basil Hetzel Institute for Translational Health Research, Adelaide, South Australia, Australia.
- College of Health, Adelaide University, Adelaide, South Australia, Australia.
ORCID-Profile: D Bogatic
Zitieren
APA
Bogatic, D., Costello, S. P., & Bryant, R. V. (2026). Letter: Dose and Donor Matter—Determining the Optimal Strategy for Faecal Microbiota Transplantation in Clostridioides difficile Infection. Alimentary Pharmacology & Therapeutics, 64(3), 412-413. https://doi.org/10.1111/apt.70625
Vancouver
Bogatic D, Costello SP, Bryant RV. Letter: Dose and Donor Matter—Determining the Optimal Strategy for Faecal Microbiota Transplantation in Clostridioides difficile Infection. Alimentary Pharmacology & Therapeutics. 2026;64(3):412-413. doi:10.1111/apt.70625
BibTeX
@article{Bogatic2026,
author = {Bogatic, D and Costello, S P and Bryant, R V},
title = {Letter: Dose and Donor Matter—Determining the Optimal Strategy for Faecal Microbiota Transplantation in Clostridioides difficile Infection},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
volume = {64},
number = {3},
pages = {412--413},
doi = {10.1111/apt.70625}
}
EUVIMED